[1] Abrahams , E. and S.,Eck, 2016.The Pharmaceutical Industry and Personalized Medicine,Journal of Precision Medicine Pp 31 37 -
[2] AmstutzU,CarletonBC, 2011.Pharmacogenetic testing: time for clinical practice guidelines,Clin Pharmacol. Ther 89 924 -927
[3] BecquemontL,AlfirevicA,AmstutzU., 2011.Practical recommendations for pharmacogenomics based prescription: 2010 ESFUB Conference on Pharmacogenetics and Pharmacogenomics, 113 124 -
[4] BondioM.G.,MichlS., 2010.Die neue Medizin und ihre Versprechen,DÄ 107 -
[5] Dabrock P.,SchumpelickV,VogelB.,Freiburg, 2011.Die konstruierte Realität der sog,individualisierten Medizin 239267 -
[6] Kan Y.W. , Dozy,A.M., 1978.Antenatal diagnosis of sicklecell anaemia by D.N.A. analysis of amniotic fluid cells,Lancet 2 910 -912
[7] KowsiganM., 2017.Heart disease prediction by analyzing various parameters using fuzzy logic,Pak. J. Biotechnol 14 257 -264
[8] Motulsky A.G., 1957.Drug reactions enzymes and biochemical genetics,J. Am. Med 165 835 -837
[9] Müller H., 2012.Chancen und Risiken der Individualisierten Medizin. für das Gesundheitssystem,Welt Krankenversicherung 2 4041 -
[10] Patrinos G.P. , Kollia,P. , Papadakis,M.N., 2005.Molecular diagnosis of inherited disorders: lessons from hemoglobinopathies,Hum Mutat 26 399 -412
[11] PHGFoundation,Oct., 2016.StratifiedMedicine: Many Names for One Concept or Many, Assessed, -
[12] RellingM.V.,AltmanR.B.,GoetzM.P.,EvansW. E., 2010.Clinical implementation of pharmacogenomics: overcoming genetic exceptionalism,Lancet Oncol 11 507 -509
[13] RellingM.V.,KleinT.E., 2011.,CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network. Clin. Pharmacol. Ther 89 464 -467
[14] Schleidgen S. , Marckmann,G., 2013.Alter Wein in neuen Schläuchen? Ethische Implikationen der Individualisierten Medizin,Eth. Med 25 223 -231
[15] Scott S.A. , Edelmann,L. , Liu,L. , Luo,M. , Desnick,R.J. , Kornreich,R., 2010.Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases,Hum Mutat 31 1240 -1250
[16] Swen J.J. , Nijenhuis,M. , de Boer,A., 2011.Pharmacogenetics: from bench to byte-an update of guidelines,Clin. Pharmacol. Ther 89 662 -673
[17] Valdes R. , Payne,D., 2010.Application of Pharmacogenetics to Clinical Practice: National Academy of Clinical Biochemistry. Laboratory medicine practice guidelines (,Laboratory Analysis -
[18] Vollmann J., 2013.Kritische medizinethische Anfragen an die, personalisierte Medizin,Eth Med -